Immunovant, Inc. Quarterly Depreciation in USD from Q2 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Immunovant, Inc. quarterly/annual Depreciation history and growth rate from Q2 2019 to Q2 2024.
  • Immunovant, Inc. Depreciation for the quarter ending June 30, 2024 was $80K, a 50.9% increase year-over-year.
  • Immunovant, Inc. annual Depreciation for 2023 was $231K, a 19.7% increase from 2022.
  • Immunovant, Inc. annual Depreciation for 2022 was $193K, a 53.2% increase from 2021.
  • Immunovant, Inc. annual Depreciation for 2021 was $126K, a 93.8% increase from 2020.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $80K +$27K +50.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q2 2023 $53K +$9K +20.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q2 2022 $44K +$18K +69.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q2 2021 $26K +$16K +160% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q2 2020 $10K +$5K +100% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q2 2019 $5K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.